학술논문

Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer
Document Type
Journal
Source
JOURNAL OF THORACIC ONCOLOGY; SEP 2009, 4 9, pS444-pS444, 1p.
Subject
Language
English
ISSN
15560864